Latest editorial
Flynn and Pfizer fined £70m for overcharging NHS for epilepsy drugs
PHARMACEUTICAL companies Flynn and Pfizer have been fined nearly £70 million after they overcharged the NHS for a life-saving epilepsy drug, the Competition and Markets Authority (CMA) announced today.
The body said that the two drug companies had illegally “abused their dominant positions” in the market to charge unfairly high prices over four years.
Costs to the NHS for the phenytoin sodium drug increased from £2m in 2012 to £50m in 2013.
Similar stories
Politicians who continue to welcome contracts with US companies without considering the risks and consequences of total dependency in the years to come are undermining the raison d’etre of the NHS, argues Dr JOHN PUNTIS
Born from my communist social worker mother’s efforts to bridge healthcare gaps, Labour’s push for home-based care now risks becoming another avenue for the US corporate takeover of the NHS, writes RICHARD CLARKE
More than seven in 10 health workers says patients struggling with their bills — a public health crisis ‘that is entirely preventable’